New diabetes clinical trial: Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy

Published on: January 07, 2025 at 11:00PM
Conditions: Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8; Invasive Breast Carcinoma
Interventions: Procedure: Biospecimen Collection; Other: Educational Intervention; Drug: Extended Release Metformin Hydrochloride; Other: Questionnaire Administration
Sponsors: City of Hope Medical Center; National Cancer Institute (NCI)
Recruiting
https://ift.tt/yNbWJei